James George Robinson, Director at NYMOX PHARMACEUTICAL CORP (NYMX), bought 9,000 shares at $1.54 ($14K) on 2019-06-27, disclosed to the SEC on 2019-06-28.
Open-market purchase of $14k NYMX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.54 | 527 | $812 | 5.8% |
| 2 | $1.55 | 473 | $733 | 5.2% |
| 3 | $1.56 | 32 | $50 | 0.4% |
| 4 | $1.56 | 1,733 | $3K | 19.3% |
| 5 | $1.56 | 6,235 | $10K | 69.4% |
| Total | $1.56 avg | 9,000 |
| $14K |
| 100% |
| Filing → |
| NYMX | BUY | 2022-05-06 | $3.8M | — | Filing → |
| NYMX | BUY | 2021-04-27 | $83K | — | Filing → |
| NYMX | BUY | 2019-07-12 | $12K | — | Filing → |